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http://dxObjectives: This study derived and validated a risk index for postoperative renal failure after orthotopic heart
transplantation.
Methods: Adult orthotopic heart transplantations performed between 2000 and 2010 were identified in the
United Network for Organ Sharing database. Patients were randomly divided 4:1 into derivation and validation
cohorts. The primary outcome was new-onset postoperative renal failure requiring dialysis. A multivariable
model was created incorporating variables associated with renal failure in univariate analysis, with significant
risk factors assigned points based on odds ratios. A simple guide was generated to demonstrate ranges of risk
scores associated with clinically meaningful renal failure rates.
Results: A total of 14,635 orthotopic heart transplantation recipients were included. New-onset postoperative
renal failure occurred in 1128 patients (7.7%). A 100-point risk score was generated using 13 significant risk
factors. There was a high degree of correlation between actual renal failure rates in the validation cohort and
predicted rates in the derivation cohort based on risk scores (r ¼ 0.91, P<.001). Renal failure risk categories
were generated on the basis of probabilities determined in the derivation cohort: low (<5% risk, score 0-15),
average (5%-10% risk, score 16-26), above average (10%-20% risk, score 27-39), and high (>20% risk, score
40). The actual renal failure rates in the validation cohort for these risk score ranges corresponded to the risk
category theywere assigned to: score 0 to 15 (4.1% rate), score 16 to 26 (6.8% rate), score 27 to 39 (13.2% rate),
and score 40 or more (20.2% rate).
Conclusions: This 100-point risk index incorporating 13 risk factors is highly predictive of new-onset
postoperative renal failure after orthotopic heart transplantation. Prospective assessment of orthotopic heart
transplant recipients using the risk categories that were generated on the basis of score ranges may help in
tailoring perioperative management. (J Thorac Cardiovasc Surg 2014;148:1099-105)Although variable, the incidence of acute kidney injury after
orthotopic heart transplantation (OHT) has been reported as
high as 40% to 70%.1-3 Acute kidney failure represents a
substantial proportion of these cases and is associated with
postoperative mortality rates of upward of 35% to 50%.2,4
Furthermore, postoperative acute renal failure represents a
significant risk factor for developing chronic kidney disease
after OHT, which occurs in approximately 10% of OHT
recipients by 5 years post-transplant.5 Beyond its direct
impact on patient outcomes, acute renal failure is associated
with significant increases in resource use and cost.6
Although risk factors for acute renal failure afterOHThave
been identified, there is no simple clinical guide to estimatee Division of Cardiac Surgery, Department of Surgery, The Johns Hopkins
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The Journal of Thoracic and Caroverall risk. Such a guide would be useful to clinicians in
tailoring perioperative management and stratifying patients
for research studies according to baseline risk. The objective
of this studywas to derive and validate a composite risk index
for postoperative renal failure after OHT.T
XMETHODS
Database
This study used the United Network for Organ Sharing (UNOS)
database. This registry contains patient-level data on all solid-organ
transplants performed in the United States. The institutional review board
granted this study exempt status because the data are publically available
and de-identified. All statistical analyses were performed using Stata
version 11 software (StataCorp LP, College Station, Tex).
Study Population
The study population consisted of adult patients aged 18 years or more
undergoing OHT in the United States between January 1, 2000, and
December 31, 2010. Patients undergoing simultaneous multiorgan
transplants or redo OHTwere excluded from analysis. Patients on dialysis
before OHT also were excluded.
Baseline Study Population Characteristics
Baseline characteristics were initially summarized. These included
recipient, donor, and operative variables. All variables provided bydiovascular Surgery c Volume 148, Number 3 1099
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XUNOS were evaluated. The full listing of variables available in the UNOS
registry can be found at http://www.unos.org.
Derivation and Validation Cohorts
The study population was randomly divided into derivation and
validation cohorts in a 4:1 ratio. Baseline characteristics were then
compared between the derivation and validation cohorts. These included
all recipient, donor, and operative variables.
Generation of Risk Index in the Derivation Cohort
The primary outcome for this analysis was new-onset postoperative acute
renal failure requiringdialysis. The associationbetweeneachvariable provided
byUNOS and postoperative acute renal failurewas tested in univariate logistic
regression analysis in the derivation cohort. Variables associated with postop-
erative renal failure in univariate analysis (exploratoryP value<.20)were then
entered into a multivariable logistic regression model. Variables with>25%
missing data were excluded from entry into the model. The inclusion of
covariates and performance of the final multivariable model were evaluated
using the Hosmer–Lemeshow goodness-of-fit test, McFadden’s pseudo-R2,
Akaike information criterion, likelihood ratio test, and area under the receiver
operating curve. Continuous data were categorized on the basis of receiver
operating characteristic analysis and graphically displaying splines to
identify break points. Points were then assigned to each significant covariate
in the final multivariable model. The magnitude of the points corresponded
to the relative magnitude of the odds ratio for that covariate. Moreover, we
multiplied the odds ratio by a factor of 4 and rounded to the nearest whole
number to arrive at the number of risk points assigned to each risk factor. A
composite risk index was then generated for each patient by simply summing
the individual points. A probability curvewas generated to visually display the
oddsofpostoperative renal failure foreach scorebasedon thederivationcohort.
Validation of Risk Index
Composite risk scores were calculated for each patient in the validation
cohort. The performance of the risk index in the validation cohort was
initially evaluated using logistic regression analysis. Aweighted regression
analysis was performed to evaluate the association between predicted renal
failure rates based on the derivation cohort for each score and actual
observed renal failure rates in the validation cohort for that same score.
Weights were assigned on the basis of the frequency of each score.
Clinical Guide to Estimate Renal Failure Risk
A simple guidewas generated that demonstrated the range of risk scores
associated with clinically meaningful renal failure rates in the derivation
cohort. The categories of renal failure risk were defined as follows: low
(<5%), average (5%-10%), above average (10%-20%), and high
(20%). The average renal failure rate observed in the validation cohort
for patients within these same ranges of risk scores were then evaluated
to determine whether they corresponded to the rates provided in the guide.RESULTS
Baseline Characteristics
A total of 14,635 patients were included in this analysis.
The average recipient age was 52.2  12.2 years (Table 1).1100 The Journal of Thoracic and Cardiovascular SurSome 76% of patients were male, and 73% were
Caucasian. There was a similar proportion of ischemic heart
disease and idiopathic dilated cardiomyopathy. The mean
preoperative serum creatinine was 1.27  0.46 mg/dL.
Only 2% and 5% of patients required mechanical
ventilation or an intra-aortic balloon pump before OHT,
respectively, although 21% were bridged with a ventricular
assist device. In comparing the derivation and validation
cohorts, there were no differences in key recipient
characteristics except for serum bilirubin, which was higher
in the validation cohort (Table 1).
The mean donor age was 31.4  12.2 years (Table 1).
Similar to recipients, most donors were male and Cauca-
sian. In 59% of donors, the mechanism of death was
trauma-related. The average center OHT volume was 24.7
 17.7 per year. The mean ischemic time was 3.20 
1.04 hours. There were no differences in donor or operative
characteristics between the derivation and validation co-
horts (Table 1).
Generation of Risk Score in the Derivation Cohort
New-onset postoperative renal failure occurred in 1128
patients (7.7%) in the entire study population. A total of
11,689 patients (80%) were randomly assigned to the
derivation cohort. A total of 15 variables were associated
with postoperative renal failure in the derivation cohort in
univariate analysis and therefore included in the multi-
variable model: older age, congenital heart disease or
‘‘other’’ heart failure cause, reduced creatinine clearance,
increased serum bilirubin, increased body mass index,
diabetes mellitus, mechanical ventilation, intensive care
unit before OHT, recent infection requiring intravenous
antibiotics, blood transfusion while on the waitlist,
previous malignancy, older donor age, female donor,
biatrial anastomosis, and longer ischemic time (Table 2).
The risk factors that were significant predictors of renal
failure in the final model included age 60 years or more,
congenital heart disease or ‘‘other’’ heart failure cause,
creatinine clearance less than 60 mL/min, serum bilirubin
1 mg/dL or greater, body mass index 30 kg/m2 or greater,
diabetes mellitus, mechanical ventilation, intensive care
unit before OHT, recent infection, blood transfusion on
waitlist, donor age 30 years or more, biatrial anastomosis,
and ischemic time 4 hours or more (Table 2). The final
multivariable model had an area under receiver operating
characteristic curve of 0.70, Akaike information criterion
of 5896, and a nonsignificant Hosmer–Lemeshow chi-
square of 15.4. Individual risk points varied from as low as
5 each for age 60 years or more, serum bilirubin 1 to 1.9
mg/dL, body mass index 30 to 34.9 kg/m2, diabetes
mellitus, intensive care unit before OHT, and donor age 30
to 49 years, to 15 points for creatinine clearance less than
30 mL/min and 16 points for congenital heart disease. Over-
all, the composite risk index was out of 100 possible points.gery c September 2014
TABLE 1. Baseline study population characteristics
Variable Study population (n ¼ 14,635) Derivation cohort (n ¼ 11,689) Validation cohort (n ¼ 2946) P value*
Recipient
Age (y) 52.2  12.2 52.1  12.2 52.5  12.2 .21
Female 3495 (24%) 2757 (24%) 738 (25%) .10
Caucasian race 10,689 (73%) 8519 (73%) 2170 (74%) .50
Heart failure cause .98
Ischemic 6477 (44%) 5163 (44%) 1314 (45%)
Dilated CM 6316 (43%) 5054 (43%) 1262 (43%)
Congenital 369 (3%) 294 (3%) 75 (3%)
Other 1473 (10%) 1178 (10%) 295 (10%)
Diabetes mellitus 3398 (23%) 2692 (23%) 706 (24%) .28
Body mass index (kg/m2) 26.7  4.9 26.7  4.9 26.6  4.9 .22
Serum creatinine (mg/dL) 1.27  0.46 1.26  0.46 1.27  0.47 .38
Serum bilirubin (mg/dL) 1.22  1.98 1.21  1.85 1.29  2.46 .03
Mechanical ventilation 329 (2%) 258 (2%) 71 (2%) .51
Intra-aortic balloon pump 704 (5%) 561 (5%) 143 (5%) .90
Bridged with ventricular assist device 3076 (21%) 2460 (21%) 616 (21%) .87
Intensive care unit 4203 (29%) 3350 (29%) 853 (29%) .75
Recent infection 1517 (10%) 1209 (10%) 308 (10%) .86
Blood transfusion on waitlist 2993 (20%) 2377 (20%) 616 (21%) .49
Donor
Age (y) 31.4  12.2 31.4  12.2 31.4  12.2 .84
Female 4092 (28%) 3264 (28%) 828 (28%) .84
Caucasian race 9966 (68%) 7986 (68%) 1980 (67%) .25
Mechanism of death .73
Trauma 8609 (59%) 6858 (59%) 1751 (59%)
Cerebrovascular 4656 (32%) 3736 (32%) 920 (31%)
Other 1366 (9%) 1092 (9%) 274 (9%)
Operative
Biatrial anastomosis 8619 (59%) 6884 (59%) 1735 (59%) .99
Average annual center OHT volume 24.7  17.7 24.6  17.6 24.9  17.9 .50
Ischemic time (h) 3.20  1.04 3.20  1.04 3.20  1.05 .93
CM, Cardiomyopathy;OHT, orthotopic heart transplantation. *P value comparing derivation versus validation cohorts based on chi-square for categoric data and Student t test for
continuous data. Categoric data presented as number (percentage). Continuous data presented as mean  standard deviation.
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19.8  9.8, with a range of 0 to 76. A probability curve of
predicted postoperative renal failure rates based on risk
score was generated using derivation cohort data
(Figure 1). The predicted renal failure rate ranged from
1.8% (95% confidence interval [CI], 1.5-2.2) for a score
of 0 to 74.0% (95% CI, 66.8-80.0) for a score of 76. A sim-
ple guide was constructed that provided a range of risk
scores associated with clinically meaningful renal failure
rates (Table 3).
Validation of Risk Score in the Validation Cohort
A total of 2946 patients (20%) were randomly assigned
to the validation cohort. The mean risk score in the valida-
tion cohort was 20.2 9.8, with a range of 0 to 57. The risk
score was highly predictive of postoperative renal failure
requiring dialysis in the validation cohort (odds ratio,
1.06; 95% CI, 1.04-1.07; P < .001). The multivariable
model had similar performance in the validation cohort as
the derivation cohort with a c-index of 0.70, AkaikeThe Journal of Thoracic and Carinformation criterion of 1526, and nonsignificant
Hosmer–Lemeshow chi-square of 3.7. In weighted
regression analysis, there was a high degree of correlation
between predicted renal failure rates based on the derivation
cohort and actual renal failure rates in the validation cohort
(r ¼ 0.91, P<.001) (Figure 2).
The actual renal failure rates in the validation cohort for
the ranges of scores in the guide in Table 3 were within the
range of predicted rates based on the derivation cohort
(Figure 3). Moreover, in the validation cohort, patients pre-
dicted to be low risk with a score of 0 to 15 had an actual
renal failure rate of 4.1%. Patients predicted to be average
risk with a score of 16 to 26 had an actual renal failure rate
of 6.8%. Likewise, patients predicted to be at above
average risk with a score of 27 to 39 had an actual renal fail-
ure rate of 13.2%. Finally, patients in the validation cohort
predicted to be at high risk based on the derivation cohort
with a score of 40 or higher had an actual renal failure
rate of 20.2%. These rates corresponded well to the renal
failure rates observed in the derivation cohort for thediovascular Surgery c Volume 148, Number 3 1101
TABLE 2. Final multivariable logistic regression model used to








Age 60 y 1.21 (1.03-1.42) .02 5
Heart failure cause
Dilated CM Reference Ref. 0
Ischemic heart disease 0.98 (0.83-1.15) .81 0
Congenital heart disease 4.01 (2.88-5.60) <.001 16
Other 1.54 (1.22-1.93) <.001 6
Creatinine clearance
(mL/min)
60 Reference Ref. 0
30-59 1.92 (1.65-2.23) <.001 8
<30 3.86 (2.80-5.32) <.001 15
Serum bilirubin (mg/dL)
<1 Reference Ref. 0
1-1.9 1.29 (1.10-1.51) .002 5
2-2.9 1.55 (1.19-2.04) .001 6
3 1.78 (1.38-2.30) <.001 7
Body mass index (kg/m2)
<18.5 Reference Ref. 0
18.5-24.9 1.24 (0.84-1.82) .29 0
25-29.9 1.14 (0.96-1.35) .14 0
30-34.9 1.36 (1.11-1.67) .003 5
35 1.43 (1.03-1.99) .04 6
Diabetes mellitus 1.26 (1.07-1.49) .006 5
Mechanical ventilation 2.31 (1.66-3.23) <.001 9
Intensive care unit 1.32 (1.13-1.54) <.001 5
Recent infection 1.59 (1.30-1.95) <.001 6
Blood transfusion on
waitlist
1.43 (1.21-1.69) <.001 6
Previous malignancy 0.93 (0.68-1.27) .65 Not included
Donor
Donor age (y)
<30 Reference Ref. 0
30-49 1.19 (1.02-1.39) .02 5
50 1.69 (1.35-2.12) <.001 7
Female donor 1.09 (0.93-1.28) .27 Not included
Operative
Biatrial anastomosis 1.19 (1.04-1.38) .01 5
Ischemic time (h)
<4 Reference Ref. 0
4-5.9 1.43 (1.21-1.68) <.001 6
6 1.92 (1.15-3.22) .01 8
CI, Confidence interval; CM, cardiomyopathy.
FIGURE 1. Probability of new-onset postoperative acute renal failure
based on risk score in the derivation cohort. CI, Confidence interval.
TABLE 3. A simple guide demonstrating the range of risk scores
associated with clinically meaningful new-onset postoperative acute
renal failure rates
Range of risk scores
Predicted postoperative
renal failure rate Risk category
0-15 <5% Low
16-26 5%-10% Average
27-39 10%-20% Above average
40 20% High
Cardiothoracic Transplantation and Mechanical Circulatory Support Kilic et al
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26 (7.1%), score 27 to 39 (13.7%), and score 40 or more
(23.9%) (Figure 3). There was also a correlation between
risk score and 30-day mortality, with 30-day mortality rates
that were 2.1%, 4.2%, 7.4%, and 15.8% for patients
with scores associated with the lowest to highest renal
failure risk categories, respectively (odds ratio for 30-day
mortality, 1.06; 95% CI, 1.06-1.07; P<.001).1102 The Journal of Thoracic and Cardiovascular SurDISCUSSION
In this study of 14,635 patients undergoing OHT, we
derived and validated a 100-point risk score for new-onset
postoperative acute renal failure requiring dialysis
incorporating 13 recipient, donor, and operative variables.Individual Risk Factors for Renal Failure
The strongest risk factors for postoperative renal failure
in our analysis included congenital heart disease, reduced
preoperative creatinine clearance, mechanical ventilation
before OHT, and prolonged ischemic time. In a prior
UNOS analysis of 689 adult patients with congenital heart
disease undergoing OHT, the rate of postoperative dialysis
was 18% in this higher-risk patient subset compared with
8% in OHT recipients with other heart failure causes.7
Another study of 756 OHT recipients between 1993 and
2004 found that increased preoperative serum creatinine
was a significant risk factor for postoperative acute kidney
injury in multivariable analysis.4 Other significant
predictors in the latter study included lower serum albumin
level, insulin-dependent diabetes, and longer cardiopulmo-
nary bypass time.
In a pooled analysis of thoracic organ transplants at a
single center, mechanical ventilation was found to correlate
with the degree of acute kidney injury, with intraoperative
blood transfusion and preexisting impaired renal function
being independent predictors.8 Prolonged ischemic time
also has been demonstrated to be a risk factor for acute renal
failure after OHT.9gery c September 2014
FIGURE 2. Weighted regression analysis demonstrating the significant
association between predicted renal failure rates based on the derivation
cohort and actual observed renal failure rates in the validation cohort.
Kilic et al Cardiothoracic Transplantation and Mechanical Circulatory SupportAn analysis of 65 OHT recipients identified recipient age,
which was included in our risk score as a significant risk
factor, and the use of cyclosporine as independent
predictors of postoperative renal failure.3 Of note, biatrial
anastomosis was identified as a risk factor in our study.
Prior studies have demonstrated decreased survival with
the biatrial technique in part due to worse hemodynamics
and right ventricular function compared with the bicaval
technique.10,11 Although not directly reported, it is
conceivable that the higher likelihood of impaired forward
flow with the biatrial technique would predispose OHT
recipients to an increased risk of renal failure when
compared with bicaval anastomoses.Clinical Utility of the Risk Score
A risk score to be used in the clinical realm ideally should
be easy to calculate. Some risk scores, such as the Society
for Thoracic Surgeons’ risk calculators for coronary artery
bypass grafting or valve surgery, are able to simplify the
process through web-based entry and automated
calculation.12,13 We believe our risk score fulfills this
criteria because the components of the score are easy toFIGURE 3. Actual rates of new-onset postoperative acute renal failure by
risk categories.
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risk factors.
Another important aspect of a clinically useful risk score
is that a wide range of outcomes are predicted when
comparing scores at the low versus high end of the risk
spectrum. Again, we believe our composite risk index
fulfills this criteria. In the derivation cohort, the predicted
risk of renal failure ranged from a very low 1.8% for a score
of 0 to a very high risk of 74.0% for a score of 76, clearly a
broad range of risk.
The true impact of a risk score depends on how it will be
used to influence patient care and decision-making. In this
effort, we devised a simple guide to categorize patients as
low, average, above average, or high risk for renal failure
after OHT, as shown in Table 3. This guide was based on
data in the derivation cohort and confirmed to be accurate
in the validation cohort. The range of risk is broad within
the guide, with low-risk patients having less than 5% risk
and high-risk patients having greater than 20% risk of
postoperative renal failure.
We believe this guide provides a broad enough range of
renal failure risk to affect patient care. Moreover,
decisions regarding fluid management and diuresis, use of
nephrotoxic agents, including immunosuppressive agents
and induction therapy, monitoring of renal function by
conventional methods and newer technologies, and early
institution of renal replacement therapy may be affected
by such a guide. For example, a stronger case may be
made to avoid aggressive diuresis and the use of
nephrotoxic agents in the high-risk category. In addition,
more frequent monitoring of renal function, including early
consultation with nephrologists, may be more appropriate
for higher-risk patients. The development of new urine or
serum biomarkers for acute renal failure also may be higher
yield and more cost-effective in this higher-risk category of
recipients.14
Another important application of the risk score and guide
may be in translational and clinical research. For instance,
induction therapy is currently used in approximately 50%
of OHT recipients.15 Its main objectives are not only to
provide early, intense immunosuppression but also to delay
initiation of potentially nephrotoxic immunosuppressives
beyond the early postoperative period when susceptibility
to renal injury is greatest. Stratifying patients according to
renal failure risk in clinical studies to better define the
role of induction therapy in OHT may be helpful. In
particular, patients in the highest risk category may
benefit the most from avoidance of nephrotoxic agents.
Furthermore, as previously mentioned, novel serum and
urinary biomarkers are being developed for acute renal
failure.14 The predictive values of these biomarkers may
be greatest in the higher-risk categories where the preva-
lence of kidney failure is higher. In addition, using these
biomarkers to monitor for renal failure postoperativelydiovascular Surgery c Volume 148, Number 3 1103
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again because the prevalence will be higher and costs
associated with renal failure potentially avoided if
clinical action can be undertaken to prevent further renal
deterioration and eliminate the need for dialysis.
Finally, our composite risk score and guide may have
utility in informing patients and their families about OHT
and its associated risks. More specifically, the guide in
Table 3 can be used to give a realistic impression of what
the risks are of needing dialysis at least temporarily in the
postoperative period. Although our score is a predictor of
acute renal failure and not necessarily the need for chronic
dialysis, the former is certainly a risk factor for the latter. In
a future study, it may be important to evaluate the specific
rates of chronic dialysis stratified by acute renal failure
risk category, because ongoing dialysis would certainly
affect a patient’s quality of life and may therefore be
important to disclose in the consenting process.
Study Limitations
An important limitation of our study is that other
variables that may affect rates of renal failure are not
available in the UNOS database and therefore are unable
to be included in our risk index. These variables include
the use of nephrotoxic medications, perioperative fluid
balance, intraoperative and postoperative bleeding, and
episodes of perioperative hypotension, to name a few. In
addition, the decision to dialyze a patient can vary between
providers and between institutions. There is a possibility
that a patient who was categorized as having renal failure
requiring dialysis in our study may not have been dialyzed
with a different provider or at a different institution.
Another limitation is that our analysis was confined to the
postoperative period, but there is a possibility that an
OHT recipient may have been readmitted after hospital
discharge and subsequently dialyzed. Finally, our analysis
is limited to renal failure requiring dialysis and did not
evaluate less severe forms of acute kidney injury, because
these data are not available in the UNOS registry.
CONCLUSIONS
This study derived and validated a composite risk index
for postoperative acute renal failure requiring dialysis after
OHT using data from 14,635 patients. The risk score was
then used to construct a simple clinical guide to provide cli-
nicians the ability to prospectively estimate postoperative
renal failure risk in OHT recipients. The risk index and
clinical guide may have potential applications in guiding
the perioperative management of OHT recipients and in
clinical research stratification. Because postoperative acute
renal failure is a powerful predictor of mortality, other
morbidity, and resource use, continued improvement in
preventing its occurrence and optimizing its management
is essential.1104 The Journal of Thoracic and Cardiovascular SurReferences
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Dr Mark Slaughter (Louisville, Ky). In the preoperative vari-
ables that were evaluated, it appears as though transpulmonary
gradient and pulmonary vascular resistance were not included.
These can affect donor right ventricular function and lead to
low-flow output situations and poor renal perfusion. Were these
variables not available, and what influence would they have on
the risk score if included?
Dr Kilic. Some hemodynamic variables are inconsistently
recorded in the UNOS database. Those variables that had more
than 20% missing data were excluded as potential risk factors in
our score calculation. Other hemodynamic variables did not
meet entry criteria for our multivariable model. The other item
with the hemodynamic parameters is exactly when they’re being
measured. In the UNOS database, they are measured as close togery c September 2014
Kilic et al Cardiothoracic Transplantation and Mechanical Circulatory Supportthe heart transplantation as possible, which I think is a reliable
measure. However, again because of the high percentage of
missing data or the lack of predictive power, those variables
were excluded.
Dr Slaughter. Similarly, for preoperative variables, I’m
surprised that status 1A and 1B were not included. You would
think a higher-risk individual might be at higher risk for renal
failure.
Dr Kilic. We looked at each component of what would
determine a patient to be UNOS status 1 or 2. So bridging with
ventricular assist devices, extracorporeal membrane oxygenation,
patients on inotropes, all those variables were looked at and
evaluated in the analysis. Some of those variables were significant
in univariate analysis; however, after our statistical methodology,
they did not meet inclusion criteria for the final multivariable
model.
Dr Slaughter. Although mentioned as limitations, operative
events that result in bleeding, transfusion, hypotension, and
decreased donor organ function will significantly affect post-
operative renal function. Do you think your risk score is just a
surrogate marker for those patients who will not tolerate
perioperative complications?
Dr Kilic. That’s an excellent point, and it is something we can’t
control for because those variables are not present in the UNOS
database. So it’s difficult to tell. It may very well be a surrogate.
Dr Slaughter. The concern would be if you have a patient with
a predicted 20% risk. The question is, are you going to exclude that
patient? But if you have a perfect operation, once again, the odds
are the patient probably will be okay.
Last, along these lines, will the risk score change your approach
to managing patients? An example is a patient with decreased renal
function, diabetes, and age more than 60 years, thus a high-risk
patient for post-transplant renal failure; should that patient
automatically get a ventricular assist device to demonstrate
improvement in renal function before receiving a transplant that
might lead to better organ allocation?
Dr Kilic. That’s one of the potential applications of this risk
score. Other applications would be looking at induction therapy,
for instance. Approximately 50% of transplant recipients receive
induction therapy, and it would be interesting to look at those
patients who are at very high risk for renal failure preoperatively
whether or not induction therapy would be more useful or not.
These are all potential clinical applications and certainly deserve
more attention.
Dr Robert Higgins (Columbus, Ohio). Yes, I agree, Dr Kilic, a
very articulate description of a complicated issue. I guess the ques-
tion I had in this risk-adverse world, knowing that we are trying to
optimize outcomes for these heart transplant recipients, is should
we now use this tool as a discriminator of patients who are at
risk for renal failure in the perioperative period? Can creatinineThe Journal of Thoracic and Carclearance less than 30 be a marker for impending renal failure
postoperatively? Maybe they shouldn’t even be considered for
heart transplant alone but rather heart-kidney transplantation,
which would then allow you to mitigate the effects of whatever
risk factors or variables are being played out here.
Dr Kilic. When we’re talking about patient selection, which
patients should undergo heart transplantation, we should focus
on models that are looking at postoperative or 1-year mortality
risk. Renal failure is a strong predictor for mortality, but there
are other components that certainly contribute to overall mortality
risk.
The utility of this score is to specifically tailor certain aspects of
postoperative management and in terms of clinical research strat-
ification. In terms of being a score that we look at for determining
patient selection, again, I think models that are aimed at measuring
risk of overall mortality are the models we should look at for that.
Dr Higgins.Yes, this may be a tool that would be effective for a
lot of people.
Dr Thoralf Sundt (Boston, Mass). My question relates to hav-
ing sat for many hours in transplant selection conferences
agonizing over whether the patient ought to have a heart or a
heart-kidney. How many times have we had that discussion? The
cardiologist or nephrologist says, ‘‘Oh, the kidneys will get bet-
ter,’’ and sometimes you say it too.
Are you able to look within your own institutional database at
those patients who had dodgy renal function preoperatively and
separate those who did or did not get better and use this score to
distinguish them? Is this actually applicable to the related
question, will somebody with preoperative renal failure get better
after a transplant or not?
Dr Kilic. Yes. Again, unfortunately, the UNOS database is
limited in terms of the amount of postoperative data it has. Renal
failure is simply coded as whether it’s present or not, and that’s
only in cases where dialysis is needed. But I agree, looking at a
single institution series where you have more clinical data
available, including postoperative creatinine levels and other
markers of renal failure, would be very interesting.
Dr Sundt. That’s where you’d need to do it, in your own
database. Thanks.
Dr Glenn Whitman (Baltimore, Md). We too suffer every
Tuesday afternoon with the dilemma of doing an isolated heart
transplant versus a dual-organ transplant, pulling the kidney with
the heart. Or, if we do not do a dual transplant, should we oversize
because of worry about right ventricular failure, elevated central
venous pressure, and postoperative renal function. But we can’t
do that study Dr Sundt just mentioned because we already use in-
duction therapy selectively in patients who we think are going to
have a high risk of renal insufficiency. Induction therapy is expen-
sive, so we do not use it uniformly, but when someone is at high
risk, we use it.diovascular Surgery c Volume 148, Number 3 1105
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